~~<i id='9AEF732818'><strike id='9AEF732818'><tt id='9AEF732818'><pre id='9AEF732818'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

comprehensive

author：leisure time 2025-09-06 04:41:59 - browse：37833

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH.

The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Can sheer will power keep patients alive in their dying hours?

explore

focus

explore

entertainment

hotspot

leisure time

MissionhealthsysteminNorthCarolina.MikeBellemeforSTATNorthCarolina’sattorneygeneralissuingHCAHealthc

WSS

What STAT readers think about the FDA and patient advocacy

How to keep neuroscience’s past racism from being its future

He's a Nobel laureate. Critics say he was misleading on Covid

SEC charges former device maker CEO with $41 million fraud

New documents shed light on MD Anderson Cancer Institute feud

He's a Nobel laureate. Critics say he was misleading on Covid

explore

comprehensive

explore

United colonoscopy coverage change 'may cost lives,' doctors say

In utero gene editing: an explainer

Medical leaders decry Supreme Court decision on affirmative action

Can sheer will power keep patients alive in their dying hours?

Apple is now the first public company to be valued at $3 trillion

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

As demand for Covid shots wanes, Moderna seeks its next success

A new nitrogen execution bill also undermines medical licensing

Apple is now the first public company to be valued at $3 trillion

Drinking less cuts risk of oral cavity, esophageal cancer: Report

focus

Can sheer will power keep patients alive in their dying hours?

Community Health Systems hospitals under DOJ investigation

Alabama frozen embryo ruling has major implications for IVF clinics

SNAP should offer more nutrition education

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Carvykti CAR

explore

entertainment

hotspot

leisure time